meganuclease
Cellectis, Precision Biosciences File Suits Against Each Other Again
NEW YORK (GenomeWeb News) – French firm Cellectis and North Carolina-based Precision Biosciences have filed two new suits against each other alleging infringement of US patents covering modified meganucleases.
Helix BioService to Promote Cellectis Products in India
Helix will promote Cellectis' Genome Positioning System line of products and services in India.
Cellectis Acquires Cyto Pulse Assets for $2M
The French firm gains access to Cyto Pulse's electroporation technologies and equipment.
Cellectis Bioresearch Inks Canadian Distribution Deal
Cedarlane will distribute Cellectis Bioresearch's kits in Canada.
Cellectis, Precision Bio Differ on EPO Decision Regarding Gene-Engineering Patent
The patent has been the subject of ongoing litigation between the French and US biotech firms.